TABLE 4.

Types of proposed interventions in the study participants in HGH.

Primary domain	Intervention	Frequency (%)
11. At the prescriber level (62)	11.2. Prescriber asked for information	4 (2.8)
	11.3. Intervention proposed to prescriber	3 (2.1)
	11.4. Intervention discussed with prescriber	55 (38.4)
12. At the patient level (17)	12.1. Patient (drug) counseling	11 (7.7)
	12.4. Spoken to family member/caregiver	6 (4.2)
13. At the drug level (60)	13.1. Drug changed	11 (7.7)
	13.2. Dosage changed	14 (9.8)
	13.3. Formulation changed	6 (4.2)
	13.5. Drug paused or stopped	21 (14.7)
	13.6. Drug started	8 (5.6)
14. Other (4)	14.1. Other intervention	4 (2.8)